source
- Emergent BioSolutions cuts 93 jobs and eliminates chief medical officer role in new restructuring planEmergent BioSolutions announced a new round of restructuring aimed at aligning the company with current business realities, disclosed alongside its second‑quarter earnings. The plan includes layin…
- AstraZeneca and BMS deny merger talks, Reuters says no dealReuters reported that rumors of a merger between AstraZeneca and Bristol Myers Squibb have been dismissed. A senior source close to the matter told Reuters there is no deal and no discussions betw…